{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:16:59Z","timestamp":1763036219762,"version":"build-2065373602"},"reference-count":27,"publisher":"Wiley","issue":"11","license":[{"start":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T00:00:00Z","timestamp":1177545600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer"],"published-print":{"date-parts":[[2007,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>BACKGROUND.<\/jats:title><jats:p>Approximately 25% of patients with metastatic breast carcinoma develop hepatic involvement during the course of their disease that further affects their survival. Systemic paclitaxel is safe and has demonstrated good antitumor activity against breast carcinoma. The objective of this prospective study was to determine the safety and antitumor activity of hepatic intra\u2010arterial paclitaxel therapy.<\/jats:p><\/jats:sec><jats:sec><jats:title>METHODS.<\/jats:title><jats:p>Ten patients with breast carcinoma and dominant liver metastases received monthly, inpatient, 24\u2010hour, continuous hepatic infusions of paclitaxel at 200 mg\/m<jats:sup>2<\/jats:sup> through an intra\u2010arterial catheter, which was placed using a percutaneous transfemoral approach.<\/jats:p><\/jats:sec><jats:sec><jats:title>RESULTS.<\/jats:title><jats:p>The mean patient age at the time of treatment was 51 years. Fifty\u2010six courses of paclitaxel were delivered. The most common treatment\u2010related toxicities were leukopenia, fatigue, nausea, and vomiting. No procedure\u2010related complications were observed. Three patients (30%) attained partial responses that lasted for 6 months, 7 months, and 48 months; and 4 other patients had stable disease for 5 months to 9 months. One patient underwent liver resection after receiving hepatic arterial infusions of paclitaxel and remained disease free for 48 months. Eight patients had received prior systemic taxane therapy alone or with other cytotoxic agents. However, no association between previous taxane exposure and the efficacy of the current regimen was established.<\/jats:p><\/jats:sec><jats:sec><jats:title>CONCLUSIONS.<\/jats:title><jats:p>Hepatic intra\u2010arterial therapy with paclitaxel at the dose level and on the schedule used in this study was safe and well tolerated and had reasonable antitumor activity against breast carcinoma involving the liver. Previous taxane exposure did not hamper the potential benefit of this approach. This regimen alone or in combination with targeted therapies deserves further investigation in patients with dominant liver metastases from breast carcinoma. Cancer 2007. \u00a9 2007 American Cancer Society.<\/jats:p><\/jats:sec>","DOI":"10.1002\/cncr.22672","type":"journal-article","created":{"date-parts":[[2007,4,26]],"date-time":"2007-04-26T11:48:38Z","timestamp":1177588118000},"page":"2190-2196","source":"Crossref","is-referenced-by-count":29,"title":["Pilot study of regional, hepatic intra\u2010arterial paclitaxel in patients with breast carcinoma metastatic to the liver"],"prefix":"10.1002","volume":"109","author":[{"given":"Luis H.","family":"Camacho","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razelle","family":"Kurzrock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alex","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diane F.","family":"Barber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David C.","family":"Madoff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael J.","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Edmund","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven A.","family":"Curley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel N.","family":"Hortobagyi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giora","family":"Mavligit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2007,5,18]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601038"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1563-2571.2001.01033.x"},{"key":"e_1_2_6_4_2","first-page":"969","article-title":"The blood supply of neoplasms in the liver","volume":"30","author":"Breedis C","year":"1954","journal-title":"Am J Pathol."},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1984.2.5.498"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(00)02074-2"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.3109\/07357909909011726"},{"issue":"1","key":"e_1_2_6_8_2","first-page":"4","article-title":"Single\u2010agent paclitaxel for the treatment of breast cancer: an overview","volume":"23","author":"Hortobagyi GN","year":"1996","journal-title":"Semin Oncol."},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.6.1858"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1021\/jm049705s"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.8.2355"},{"issue":"4","key":"e_1_2_6_12_2","first-page":"9","article-title":"Update: the M. D. Anderson Cancer Center experiencewith paclitaxel in the management of breast carcinoma","volume":"22","author":"Holmes FA","year":"1995","journal-title":"Semin Oncol."},{"key":"e_1_2_6_13_2","first-page":"917","article-title":"A case of liver metastasis of breast cancer successfully treated with paclitaxel infusion into the hepatic artery: an attempt of once weekly regimen [in Japanese]","volume":"29","author":"Iwamoto S","year":"2002","journal-title":"Gan To Kagaku Ryoho."},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1081\/CNV-200026526"},{"key":"e_1_2_6_15_2","first-page":"2076","article-title":"A case of postoperative hepatic metastasis from gastric cancer responding to hepatic arterial infusion chemotherapy of paclitaxel [in Japanese]","volume":"29","author":"Matsui S","year":"2002","journal-title":"Gan To Kagaku Ryoho."},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198212000-00014"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(20001201)89:11<2195::AID-CNCR7>3.0.CO;2-W"},{"key":"e_1_2_6_18_2","first-page":"1001","article-title":"Continuous 5\u2010day infusion of vinblastine for percutaneous hepatic arterial chemotherapy for metastatic breast cancer","volume":"71","author":"Fraschini G","year":"1987","journal-title":"Cancer Treat Rep."},{"key":"e_1_2_6_19_2","first-page":"313","article-title":"Percutaneous hepaticarterial infusion of cisplatin for metastatic breast cancer","volume":"71","author":"Fraschini G","year":"1987","journal-title":"Cancer Treat Rep."},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000421-198802000-00008"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.6.1877"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199912303412702"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200502173520723"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.07.100"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.99.297"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.05.120"},{"key":"e_1_2_6_27_2","article-title":"40% Response rate after hepatic arterial infusion of CPT\u201011 in patients with colorectal cancer metastatic to the liver","volume":"20","author":"Hu G","year":"2001","journal-title":"Proc Am Soc Clin Oncol."},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa052985"}],"container-title":["Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fcncr.22672","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cncr.22672","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T14:00:37Z","timestamp":1760277637000},"score":1,"resource":{"primary":{"URL":"https:\/\/acsjournals.onlinelibrary.wiley.com\/doi\/10.1002\/cncr.22672"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,5,18]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,6]]}},"alternative-id":["10.1002\/cncr.22672"],"URL":"https:\/\/doi.org\/10.1002\/cncr.22672","archive":["Portico"],"relation":{},"ISSN":["0008-543X","1097-0142"],"issn-type":[{"type":"print","value":"0008-543X"},{"type":"electronic","value":"1097-0142"}],"subject":[],"published":{"date-parts":[[2007,5,18]]}}}